Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01256866Phase 4Unknown
Phase 4, randomised trial of dexmedetomidine in critical illness (2 arms), sponsored by Hospital São Domingos. Primary endpoint: Incidence of delirium. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01256866.